Key Details
Price
$4.52Annual Revenue
$433.00 KAnnual ROE
-113.70%Beta
3.00Events Calendar
Next earnings date:
May 15, 2025Recent quarterly earnings:
Nov 19, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
NEW YORK, NY / ACCESSWIRE / December 24, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=118479&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 24, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=118463&wire=1 or contact Joseph E. Levi, Esq.
ASPI Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, CA / ACCESSWIRE / December 24, 2024 / ASP Isotopes Inc. (NASDAQ:ASPI) and certain of its most senior executives are now entangled in a securities class action, alleging the company deceived investors by making false and misleading statements about its advanced nuclear fuel technologies. Hagens Berman urges investors in ASP Isotopes who suffered substantial losses to submit your losses now.
NEW YORK, NY / ACCESSWIRE / December 24, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=118450&wire=1 or contact Joseph E. Levi, Esq.
SAN DIEGO, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased or otherwise acquired ASP Isotopes Inc. (NASDAQ: ASPI) securities between October 30, 2024 and November 26, 2024. ASP Isotopes is a development stage advanced materials company focused on the production, enrichment, and sale of isotopes.
NEW YORK, NY / ACCESSWIRE / December 24, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=118417&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 24, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired ASP Isotopes securities between October 30, 2024 and November 26, 2024, both dates inclusive (the "Class Period").
LOS ANGELES, CA / ACCESSWIRE / December 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between October 30, 2024 and November 26, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before February 3, 2025.
NEW YORK, NY / ACCESSWIRE / December 23, 2024 / If you suffered a loss on your ASP Isotopes Inc. (NASDAQ:ASPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/asp-isotopes-inc-lawsuit-submission-form?prid=118296&wire=1 or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / December 23, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against ASP Isotopes Inc. ("ASPI" or the "Company") (NASDAQ:ASPI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
FAQ
- What is the primary business of ASP Isotopes Common Stock?
- What is the ticker symbol for ASP Isotopes Common Stock?
- Does ASP Isotopes Common Stock pay dividends?
- What sector is ASP Isotopes Common Stock in?
- What industry is ASP Isotopes Common Stock in?
- What country is ASP Isotopes Common Stock based in?
- When did ASP Isotopes Common Stock go public?
- Is ASP Isotopes Common Stock in the S&P 500?
- Is ASP Isotopes Common Stock in the NASDAQ 100?
- Is ASP Isotopes Common Stock in the Dow Jones?
- When was ASP Isotopes Common Stock's last earnings report?
- When does ASP Isotopes Common Stock report earnings?
- Should I buy ASP Isotopes Common Stock stock now?